Abstract
Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have